Purchase Order 75N93023P01037
Award Date 8/3/23
Potential Completion Date 10/1/23
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,779.98 firm fixed price purchase order to Genscript USA Inc. for transient expression, purification and plasmid preparation services in support of AMBIS program activities. Performance will take place in Piscataway, New Jersey over a two month period concluding on September 30, 2023. The contract calls for Genscript to deliver requested biomanufacturing...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $250,000 firm fixed price purchase order to Genscript USA Inc. of Piscataway, New Jersey. The order is for gene production and protein expression services to support the agency's research efforts. Services include gene synthesis, cloning, plasmid preparation, and protein expression and purification. The sole source award was negotiated under the authority of 41 U.S.C. 1901(a)(1) based on...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $20,000 firm fixed price purchase order to Genscript USA Inc. to provide custom gene synthesis services. The contract will support NIH's research efforts at its Bethesda, Maryland campus through December 31, 2023. Genscript will deliver custom gene synthesis products to NIH researchers as part of the Institute's work to advance understanding of diseases...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $17,709 purchase order to Genscript USA Inc. to provide custom gene synthesis and expression services in support of its research efforts. The firm fixed price contract has a period of performance from September 18, 2023 through December 31, 2023 and will be carried out by Genscript at its facility located in Bethesda, Maryland. No major subcontractors or set aside designations were identified....
- The National Institute of Allergy and Infectious Diseases awarded a $16,974.27 firm fixed price purchase order to Genscript USA Inc. for antibody gene synthesis and production services. The contract was awarded on August 26, 2020, with an ultimate completion date of February 6, 2021, and was performed at Genscript's facility in Piscataway, New Jersey. This award did not utilize any set-aside designation and represents a straightforward procurement of specialized molecular biology services...
- Genscript USA Incorporated will provide gene synthesis and vector ark cloning services to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Under the terms of a $12,108 firm fixed price purchase order, Genscript will deliver the requested products and services between September 2023 and September 2024. As the prime contractor, Genscript will leverage its expertise...
- Genscript USA Inc. has been awarded a $24,705 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide services for creating customized monoclonal antibodies and plasmids in support of the agency's biomedical research efforts. As the prime contractor, Genscript will leverage its expertise in gene synthesis and monoclonal antibody development to deliver the requested biological products and services. This contract...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $150,355.40 firm fixed price purchase order contract to Genscript USA Inc., a biotechnology company, for COVID-19 research services. The contract includes DNA synthesis, cloning, plasmid preparation, and antibody expression and purification to support the Vaccine Research Center's continued COVID-19 studies. The services are to be performed at the NIH facility...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $20,827.75 purchase order to Genscript USA Inc. to provide customized protein production using a baculovirus expression system. Performance will take place in Piscataway, New Jersey over a period of approximately three months concluding in mid-December 2023. The firm fixed price contract calls for Genscript to deliver the requested proteins without further...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a biotechnology company, for "EXPRESS PLASMID PREPARATION, EXPRESS MUTAGENESIS TARGET AND CLONEARK PLASMID PREPARATION" services. The $149,984.10 contract has a completion date of September 13, 2022 and does not have a set-aside designation. Genscript has provided similar services to support...